Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs.
Qinglu ChengEvan B CunninghamSophy ShihJanaki AminJulie BruneauAdelina A ArtenieJeff PowisAlain H LitwinCurtis CooperOlav DalgardMargaret HellardPhilip BruggmannPhilippa MarksKarine LacombeCatherine StedmanPhillip ReadBehzad HajarizadehAdrian J DunlopBrian ConwayJordan J FeldGregory J DoreJason Grebelynull nullPublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2023)
Although no significant improvement was identified in health-related quality of life after HCV DAA treatment, there was a modest but significant increase in employment during study follow-up. The study findings support the need for multifaceted models of HCV care for PWID addressing a range of issues beyond HCV treatment to improve quality of life.